Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing

PURPOSEGiven regulatory approval of immune checkpoint inhibitors in patients with mismatch repair–deficient (MMR-D) cancers agnostic to tumor type, it has become important to characterize occurrenc...

[1]  S. Keam,et al.  Entrectinib: First Global Approval , 2019, Drugs.

[2]  Jason M. Johnson,et al.  Characteristics of mismatch repair deficiency in sarcomas , 2019, Modern Pathology.

[3]  L. Scott.  Larotrectinib: First Global Approval , 2019, Drugs.

[4]  J. Marshall,et al.  Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients , 2018, Cancer medicine.

[5]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[6]  Russell Bonneville,et al.  Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS , 2016, Oncotarget.

[7]  S. Ogino,et al.  Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. , 2017, The Journal of molecular diagnostics : JMD.

[8]  Marilyn M. Li,et al.  Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.

[9]  Marian Harris,et al.  Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.

[10]  Colin C Pritchard,et al.  Microsatellite instability detection by next generation sequencing. , 2014, Clinical chemistry.

[11]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[12]  Kai Ye,et al.  MSIsensor: microsatellite instability detection using paired tumor-normal sequence data , 2014, Bioinform..

[13]  M. Kloor,et al.  Absence of mismatch repair deficiency-related microsatellite instability in non-melanoma skin cancer. , 2012, The Journal of investigative dermatology.

[14]  N. Wentzensen,et al.  Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America. , 2011, International journal of cancer.

[15]  C. Cole,et al.  COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.

[16]  U. Dirksen,et al.  Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression , 2007, Journal of Cancer Research and Clinical Oncology.

[17]  A. Hartmann,et al.  Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer , 2006, Journal of Molecular Medicine.

[18]  Kathleen M Murphy,et al.  [Clinicopathological features and types of microsatellite instability in 1394 patients with colorectal cancer]. , 2020, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[19]  Lawrence J. Burgart,et al.  Development of a Fluorescent Multiplex Assay for Detection of MSI-High Tumors , 2004, Disease markers.

[20]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[21]  H. Bismuth,et al.  Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers. , 2003, Carcinogenesis.

[22]  P. Propping,et al.  Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. , 2003, The Journal of investigative dermatology.

[23]  G. Botti,et al.  Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases , 2003, Melanoma research.

[24]  P. Lazo,et al.  The molecular genetics of cervical carcinoma , 1999, British Journal of Cancer.